Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System
Integra LifeSciences Adds PET Imaging to Its Cancer Fighting XKnife System PLAINSBORO, N.J., Feb. 9, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its subsidiary, Integra Radionics, released its latest image registration software, ImageFusion™
View HTML
Toggle Summary Integra LifeSciences Acquires Theken Spine
PLAINSBORO, N.J., Aug 4, 2008 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (together "Theken") for $75 million in cash, subject to certain adjustments, and
View HTML
Toggle Summary Integra LifeSciences Acquires the Assets of Innovative Spinal Technologies, Inc.
PLAINSBORO, N.J., Sep 14, 2009 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that Integra Spine has acquired substantially all of the assets of Innovative Spinal Technologies, Inc. (IST) for $9.25 million in cash.
View HTML
Toggle Summary Integra LifeSciences Acquires SeaSpine
Integra Spine Doubles Its Distribution Network and Revenue Base in Spinal Hardware Kirt Stephenson Joins Integra as President, U.S. Spine PLAINSBORO, N.J., May 24, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired SeaSpine, Inc., a
View HTML
Toggle Summary Integra LifeSciences Acquires Rebound Therapeutics Corporation
Acquisition Adds New, Minimally Invasive Platform for Neurosurgery PLAINSBORO, N.J., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it has acquired Rebound Therapeutics, developers of
View HTML
Toggle Summary Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business
Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the
View HTML
Toggle Summary Integra LifeSciences Acquires Metasurg's Foot and Ankle Product Portfolio
PLAINSBORO, N.J., Jan. 12, 2015 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that, in December, it closed on the acquisition of the product portfolio from Metasurg. The addition of the Metasurg product portfolio enhances Integra's lower extremity
View HTML
Toggle Summary Integra LifeSciences Acquires IsoTis Creating a Global Leader in Orthobiologics
PLAINSBORO, N.J., Oct 29, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today it has acquired the shares of IsoTis, Inc. for $7.25 in cash per share of IsoTis common stock, representing total consideration to IsoTis stockholders of
View HTML
Toggle Summary Integra LifeSciences Acquires Eunoe Inc.'s Intellectual Property Estate
Integra LifeSciences Acquires Eunoe Inc.'s Intellectual Property Estate PLAINSBORO, N.J., Sept. 29, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has acquired the intellectual property estate of Eunoe, Inc.
View HTML
Toggle Summary Integra LifeSciences Acquires Arkis Biosciences Inc.
Adds Unique Solution to Integra’s Neurocritical Care Offering PLAINSBORO, N.J., July 29, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that it has acquired Arkis Biosciences Inc.
View HTML
Toggle Summary Integra LifeSciences Acquires an Exclusive Worldwide License for Novel Minimally Invasive Expandable Interbody Fusion Technology
PLAINSBORO, N.J., Feb. 17, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has entered into an exclusive worldwide license and development agreement with Stout Medical Group, LP to develop and commercialize an expandable interbody device.
View HTML
Toggle Summary Integra Issues URGENT Worldwide Recall of NeuroBalloon™ Catheter
Integra Issues URGENT Worldwide Recall of NeuroBalloon™ Catheter Integra LifeSciences Corporation, Plainsboro, New Jersey, has initiated a worldwide recall of the NeuroBalloon Catheter. There were a total of 1,924 units distributed, 258 in the United States of America 1,586 in the European
View HTML
Toggle Summary Integra Introduces Line Extension for Nerve Injury Products
Integra Introduces Line Extension for Nerve Injury Products PLAINSBORO, N.J., Sept. 23, 2005 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Integra NeuroSciences has enhanced its product offering for the treatment of peripheral nerve injuries.
View HTML
Toggle Summary Integra Foundation Donates $130,000 for Hurricane Katrina Relief Effort
Integra Foundation Donates $130,000 for Hurricane Katrina Relief Effort PLAINSBORO, N.J., Oct. 11, 2005 (PRIMEZONE) -- In response to the overwhelming devastation of Hurricane Katrina, the Integra Foundation, the philanthropic arm of Integra LifeSciences Holdings Corporation (Nasdaq:IART), has made
View HTML
Toggle Summary Integra Foundation Awards Grants to the Congress of Neurological Surgeons
Foundation Partners With CNS On New Education Initiative
View HTML